Plasma exchange treats severe intrahepatic cholestasis caused by dacomitinib: A case report

RATIONALE: Dacomitinib-induced liver injury is often manifested by mild elevations of transaminases and bilirubin, and severe intrahepatic cholestasis caused by dacomitinib for simultaneous taking orally cytochrome P450 2D6 (CYP2D6) competitive substrates has been rarely reported. PATIENT CONCERNS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Fei, Chen, Qinlei, Lu, Weiting, Fang, Nanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259143/
https://www.ncbi.nlm.nih.gov/pubmed/35801736
http://dx.doi.org/10.1097/MD.0000000000029629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259143/
https://www.ncbi.nlm.nih.gov/pubmed/35801736
http://dx.doi.org/10.1097/MD.0000000000029629

Ejemplares similares